Text Size
- News Releases
- What's New
- 22 Aug
- Tecentriq, an Anti-PD-L1 Antibody, Receives Approval for Additional Indication of Extensive-Stage Small Cell Lung Cancer
- 30 Jul
- Chugai Continues to be Listed for All ESG Indices Selected by GPIF
- 25 Jul
- F. Hoffmann-La Roche Announces Half Year Results 2019
- 25 Jul
- Chugai Announces 2019 Half Year Results
- 25 Jul
- Organizational and Personnel Changes
Video Introduction of CHUGAI- Share this site
